Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Portugal Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20071
20173
20182
20193
20222
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated5
Recruiting4
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Ixaka Ltd2
Sanofi2
United Therapeutics2
Alnylam Pharmaceuticals1
Amgen1
Boehringer Ingelheim1
CSL Behring1
Heidelberg University1
Ionis Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases20
Hypertension6
Stroke6
Diabetes Mellitus, Type 25
Heart Failure4
Myocardial Infarction4
Peripheral Arterial Disease3
Vascular Diseases3
Atherosclerosis2
Atrial Fibrillation2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.